In parallel, plasma cell accumulation within the HCC microenvironment dismantles antitumor immunity by producing inhibitory mediators such as PD-L1 and IL-10 and inhibiting CD8+ T-cell activation [53]. This evidence concerns the gene CD8A and hepatocellular carcinoma.